Investing Ideas
/
Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies

Header cover image

Israeli Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED May 24, 2023

Companies with a Value score of at least 3, ordered by Value score

5 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	TEVATeva Pharmaceutical Industries	US$28.19	-4.8%	-3.1%	US$8.6b	US$36.08	PB1.1x	E97.1%	0%
	KMDAKamada	₪20.05	14.6%	32.6%	₪898.9m	n/a	PS1.9x	E45.7%	n/a
	SEMGSeach Medical Group	₪1.78	0.7%	-37.0%	₪60.4m	n/a	PB0.7x	n/a	n/a
	PLXProtalix BioTherapeutics	US$7.33	-0.1%	97.5%	US$112.5m	US$41.11	PS2.4x	E129.7%	n/a
	REKARekah Pharmaceutical Industry	₪17.33	2.1%	-14.2%	₪197.8m	n/a	PB1.2x	n/a	5.0%

Page 1 of 1